Clinical trial
Long Term Effectiveness of Uterine Sparing Fibroid Treatments
NCT06430320 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Effectiveness of Uterine Sparing Fibroid Treatments
- Lead sponsor
- Henry Ford Health System
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 20, 2024
- Completion date
- August 31, 2027
- Enrollment
- 700 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
uterine fibroid